Srinivas Akkaraju, M.D., Ph.D.

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

• Identityunclaimed
  Published
• Evidencecorroborated
  Published
• Evaluationnot_evaluated
  Published
• MonitoringNot yet published for this record.
  Not published
• AuthorityNot yet published for this record.
  Not published
• Freshnesscurrent
  Published

Seats held as a director, as published in the cited sources.

1. Dates not published
   Executive title: Founder and Managing General PartnerOrganization not published
   E2

No education, credentials, or certifications are published in this record.

Who may act on this authority. An agent about to transact, or one presenting itself as acting under this authority, checks these Claims first.

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

• Only permissioned public claims and evidence are included.Only permissioned public claims and evidence are included.
• Absence of a claim is not evidence that the underlying fact is false.Absence of a claim is not evidence that the underlying fact is false.
• Public retrieval does not grant model-training or redistribution rights.Public retrieval does not grant model-training or redistribution rights.
• Private relationships and Council activity are excluded.Private relationships and Council activity are excluded.

Each relationship is one Claim rendered on every record it connects.

• KT
  Kalaris Therapeutics, Inc.Director, 2025 to present
  person:srinivas-akkaraju-m-d-ph-d:role:1
• A
  ALUMIS INC.Director, 2024 to present
  person:srinivas-akkaraju-m-d-ph-d:role:2
• VT
  vTv Therapeutics Inc.Director, 2024 to present
  person:srinivas-akkaraju-m-d-ph-d:role:3
• SR
  Scholar Rock Holding CorpDirector, 2022 to present
  person:srinivas-akkaraju-m-d-ph-d:role:4
• ON
  Organization not publishedExecutive title: Founder and Managing General Partner, Dates not published
  person:srinivas-akkaraju-m-d-ph-d:executive_title:15

This record exists because the subject holds a public role. The subject can claim the profile, correct, dispute, or object. Subject statements appear as their own assertion state and never overwrite the evidence.

Basis

Public role at an organization in the published Registry

Sources

13 evidence records cited. 0 with redistribution rights.

Never published

Home address, family, personal contacts, health, and history unrelated to the public role

Profile claimed

No

Open disputes

0

Identity ownership

unclaimed

If the subject claims the profile, their statements appear as their own assertion state, subject attested. They never overwrite the evidence.

1. E1
   Kalaris Therapeutics, Inc. director board source

   SEC EDGAR. sec filing. Published Apr 24, 2026. Retrieved May 3, 2026. Cited by 6 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
2. E2
   KLRS DEF 14A director slate

   SEC EDGAR. sec filing. Published Apr 24, 2026. Retrieved May 1, 2026. Cited by 4 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
3. E3
   Source title not published

   sec proxy. Published Apr 24, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
4. E4
   Scholar Rock Holding director board source

   SEC EDGAR. sec filing. Published Apr 22, 2026. Retrieved May 3, 2026. Cited by 6 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
5. E5
   SRRK DEF 14A director slate

   SEC EDGAR. sec filing. Published Apr 22, 2026. Retrieved Apr 29, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
6. E6
   Source title not published

   sec proxy. Published Apr 22, 2026. Retrieved Apr 29, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
7. E7
   ALMS DEF 14A director slate

   SEC EDGAR. sec filing. Published Jun 16, 2025. Retrieved May 15, 2026. Cited by 5 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
8. E8
   Source title not published

   sec proxy. Published Jun 16, 2025. Retrieved Apr 24, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
9. E9
   Source title not published

   sec proxy. Published Apr 25, 2025. Retrieved Apr 28, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
10. E10
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
11. E11
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
12. E12
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
13. E13
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

• Srinivas Akkaraju, M.D., Ph.D. seat on Kalaris Therapeutics, Inc., effective 2025-01-01.
• Srinivas Akkaraju, M.D., Ph.D. seat on ALUMIS INC., effective 2024-01-01.
• Srinivas Akkaraju, M.D., Ph.D. seat on vTv Therapeutics Inc., effective 2024-01-01.
• Srinivas Akkaraju, M.D., Ph.D. seat on Scholar Rock Holding Corp, effective 2022-01-01.